Effect of Training Pediatric Clinicians in Human Papillomavirus Communication Strategies on Human Papillomavirus Vaccination Rates: A Cluster Randomized Clinical Trial.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 09 2021
Historique:
pubmed: 25 5 2021
medline: 20 1 2022
entrez: 24 5 2021
Statut: ppublish

Résumé

Missed opportunities for human papillomavirus (HPV) vaccination during pediatric health care visits are common. To evaluate the effect of online communication training for clinicians on missed opportunities for HPV vaccination rates overall and at well-child care (WCC) visits and visits for acute or chronic illness (hereafter referred to as acute or chronic visits) and on adolescent HPV vaccination rates. From December 26, 2018, to July 30, 2019, a longitudinal cluster randomized clinical trial allocated practices to communication training vs standard of care in staggered 6-month periods. A total of 48 primary care pediatric practices in 19 states were recruited from the American Academy of Pediatrics Pediatric Research in Office Settings network. Participants were clinicians in intervention practices. Outcomes were evaluated for all 11- to 17-year-old adolescents attending 24 intervention practices (188 clinicians) and 24 control practices (177 clinicians). Analyses were as randomized and performed on an intent-to-treat basis, accounting for clustering by practice. Three sequential online educational modules were developed to help participating clinicians communicate with parents about the HPV vaccine. Weekly text messages were sent to participating clinicians to reinforce learning. Statisticians were blinded to group assignment. Main outcomes were missed opportunities for HPV vaccination overall and for HPV vaccine initiation and subsequent doses at WCC and acute or chronic visits (visit-level outcome). Secondary outcomes were HPV vaccination rates (person-level outcome). Outcomes were compared during the intervention vs baseline. Altogether, 122 of 188 clinicians in intervention practices participated; of these, 120, 119, and 116 clinicians completed training modules 1, 2, and 3, respectively. During the intervention period, 29 206 adolescents (14 664 girls [50.2%]; mean [SD] age, 14.2 [2.0] years) made 15 888 WCC and 28 123 acute or chronic visits to intervention practices; 33 914 adolescents (17 069 girls [50.3%]; mean [SD] age, 14.2 [2.0] years) made 17 910 WCC and 35 281 acute or chronic visits to control practices. Intervention practices reduced missed opportunities overall by 2.4 percentage points (-2.4%; 95% CI, -3.5% to -1.2%) more than controls. Intervention practices reduced missed opportunities for vaccine initiation during WCC visits by 6.8 percentage points (-6.8%; 95% CI, -9.7% to -3.9%) more than controls. The intervention had no effect on missed opportunities for subsequent doses of the HPV vaccine or at acute or chronic visits. Adolescents in intervention practices had a 3.4-percentage point (95% CI, 0.6%-6.2%) greater improvement in HPV vaccine initiation compared with adolescents in control practices. This scalable, online communication training increased HPV vaccination, particularly HPV vaccine initiation at WCC visits. Results support dissemination of this intervention. ClinicalTrials.gov Identifier: NCT03599557.

Identifiants

pubmed: 34028494
pii: 2780244
doi: 10.1001/jamapediatrics.2021.0766
pmc: PMC8145158
doi:

Substances chimiques

Papillomavirus Vaccines 0

Banques de données

ClinicalTrials.gov
['NCT03599557']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-910

Subventions

Organisme : NCI NIH HHS
ID : R01 CA202261
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States

Auteurs

Peter G Szilagyi (PG)

Department of Pediatrics, University of California, Los Angeles, UCLA Mattel Children's Hospital, Los Angeles.

Sharon G Humiston (SG)

Department of Pediatrics, Children's Mercy, Kansas City, Missouri.

Alisa J Stephens-Shields (AJ)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Russell Localio (R)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Abigail Breck (A)

Department of Pediatrics, University of California, Los Angeles, UCLA Mattel Children's Hospital, Los Angeles.

Mary Kate Kelly (MK)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Margaret Wright (M)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Pediatric Research in Office Settings, American Academy of Pediatrics, Itasca, Illinois.

Robert W Grundmeier (RW)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Christina Albertin (C)

Department of Pediatrics, University of California, Los Angeles, UCLA Mattel Children's Hospital, Los Angeles.

Laura P Shone (LP)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Pediatric Research in Office Settings, American Academy of Pediatrics, Itasca, Illinois.

Jennifer Steffes (J)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Pediatric Research in Office Settings, American Academy of Pediatrics, Itasca, Illinois.

Cynthia M Rand (CM)

Department of Pediatrics, University of Rochester, Rochester, New York.

Chloe Hannan (C)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Dianna E Abney (DE)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Greta McFarland (G)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Gerald F Kominski (GF)

UCLA Center for Health Policy Research, University of California Los Angeles, Los Angeles.

Brayan V Seixas (BV)

UCLA Center for Health Policy Research, University of California Los Angeles, Los Angeles.

Alexander G Fiks (AG)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.
Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH